The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1963, 91: 771-776.
Copyright © 1963 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lenhart, N. A.
Right arrow Articles by Li, I. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lenhart, N. A.
Right arrow Articles by Li, I. W.

The Common Protein Agglutinogen of Staphylococcus Aureus

I. Distribution in International Serotypes and Corresponding Antibody in Human Populations1

N. A. Lenhart, S. Mudd, A. Yoshida2 and I. W. Li

From the United States Veterans Administration Hospital and Department of Public Health and Preventive Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Abstract

A protein agglutinogen common to the internationally recognized serotypes of Staphylococcus aureus is described. Sera of all human subjects studied, healthy or infected, possess a high and fairly uniform level of antibodies against this agglutinogen. The agglutinin is concentrated in commercial human {gamma}-globulin and is deficient in the blood of agammaglobulinemic children. No immunizing agent has been found which will regularly increase agglutination titers in man to a significant degree, although some increase has been induced in rabbits. Serum absorbed with the pure protein agglutinogen shows decreased agglutination titer against all serotypes but is not deprived of its phagocytosis promoting power.

Footnotes

1 This work was supported by a grant from the Veterans Administration Central Office Research Service, Washington, D. C., and Research Grant E-2690 from the National Institutes of Health, Bethesda, Maryland.

2 Present address: Laboratory of Molecular Biology, National Institute of Neurological Diseases and Blindness, National Institutes of Health, Bethesda 14, Maryland.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1963 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1963 by The American Association of Immunologists, Inc. All rights reserved.